Psychiatric comorbidity, such as addictive behavior, is common in a variety of treatment settings, and has far-reaching consequences. Complications from addictive behavior can impede treatment progress, lead to additional problems, and increase the chance of treatment failure. Consequently, there recently has been increased demand on medical care workers who do not specialize in addiction (e.g., nurse practitioners, general practitioners, obstetricians, trauma specialists, etc.) to assess, intervene, and provide referrals for their patients who demonstrate addictive behavior. However, research suggests that many medical care providers lack addiction-related training and resources. The goals of this online course are to improve participants’ understanding of addiction and its influence on medical care. We will discuss the theoretical and clinical aspects of addictive behavior, as well as strategies for dealing with patients who demonstrate addictive behavior.

NUMBER OF CREDIT HOURS: The Harvard Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

COST: $60.00
click here for pricing outside the United States of America

OVERALL LEARNING OBJECTIVES:

1. Discuss available evidence-based strategies and resources for assessment, brief intervention, referral, and continuing care.
2. Improve participants’ understanding of contemporary theories of addiction.
3. Show the influence of addictive behavior on medical care practice.
4. Illustrate the effects of addiction on health and wellness.

CLINICAL LEARNING OBJECTIVES:

1. Provide information related to evidence-based treatment and referral options.
2. Provide information related to treating pain of addicted individuals.
3. Provide information related to prototypical recovery and relapse.
4. Provide information related to facilitating clinical discourse about addictive behavior.

back to the top

DEBI A. LAPLANTE, PHD Course Co-Director

Debi LaPlante, Ph.D., is Associate Director of the Cambridge Health Alliance, Division on Addictions and an Instructor of Psychology in the Department of Psychiatry, Harvard Medical School. She graduated from the College of the Holy Cross with a degree in psychology and completed her graduate education in social psychology at Harvard University. At the Division on Addictions, Dr. LaPlante is involved in research, teaching, and public outreach. Her research interests include, but are not limited to: (1) psychiatric comorbidity profiles and addictive behavior, such as DUI; (2) strength of evidence estimates for treatment outcome studies; and (3) addiction in special populations, such as women and minorities. Currently, Dr. LaPlante is senior editor of the online research review, the Brief Addiction Science Information Source (The BASIS), which publishes weekly science reviews on the latest research studies of gambling, alcohol, tobacco, and drugs. She also played a lead role in the development of the Executive, Management and Employee Responsible Gaming Education (EMERGE) program for educating gaming industry employees about responsible gaming. Dr. LaPlante has written and lectured extensively about addiction and behavioral expressions of addiction, such as gambling. Through her work, her goal is to further the mission of the Division on Addictions by strengthening worldwide understanding of addiction through innovative research, education, and the global exchange of information. DISCLOSURE:

HOWARD J. SHAFFER, PHD, C.A.S Course Co-Director

Currently, Dr. Shaffer is an Associate Professor at Harvard Medical School; in addition, he is the Director of the Division on Addictions at the Cambridge Health Alliance, a teaching affiliate of Harvard Medical School. He has served as principal or co-principal investigator on a variety of government, state, non-profit/foundation, and corporate sponsored research projects. Currently, he focuses his efforts on the research and educational activities associated with the Institute for Research on Pathological Gambling and Related Disorders, Internet Gambling and his ongoing federally funded research on the psychiatric co-morbidity among multiple DUI offenders. Dr. Shaffer is the current editor of the The Psychology of Addictive Behaviors, and is the past editor of The Journal of Gambling Studies and past associate editor of The Journal of Substance Abuse Treatment. Dr. Shaffer also is a member of numerous editorial boards. Dr. Shaffer's major research interests include, the social perception of addiction and disease, the philosophy of science, impulse control regulation and compulsive behaviors, addiction treatment outcomes, psychiatric comorbidity, homelessness and addiction, and the natural history of addictive behaviors. Dr. Shaffer has written extensively about the treatment of addictive behaviors and the nature of addiction, including more than 250 chapters, journal articles, and reviews. He also has published more than 120 newspaper articles, and 10 books or monographs. His research, writing, and teaching have shaped how the health care field conceptualizes and treats the full range of addictive behaviors. DISCLOSURE: Company: Pioneer Behavioral Health Type of Relationship: Own stock

back to the top

MARK JOSEPH ALBANESE, MD Reviewer

Dr. Albanese was born in Boston, and graduated from Boston Latin School. He attended Harvard College and Cornell University Medical College. He did his internship in medicine at Brigham and Women’s Hospital, and his psychiatry residency at Massachusetts Mental Health Center. He is certified by the American Board of Psychiatry and Neurology in general psychiatry and addiction psychiatry. Dr. Albanese worked for the Massachusetts Department of Mental Health for over twelve years prior to coming to Cambridge Health Alliance (CHA) in September 2002. Most of that time he was at Tewksbury Hospital, where he served as unit medical director, residency training director, director of medical education, and associate chief of psychiatry. He has also been a consultant to several addictions programs affiliated with the Massachusetts Department of Public Health. Dr. Albanese is on the faculty of Harvard Medical School’s (HMS) Division on Addictions, where he served as Advanced Fellow in Addiction Studies. At CHA, he is Director of Addictions Treatment Services. He is also Assistant Clinical Professor of Psychiatry at HMS. In addition to his clinical, administrative, and teaching work, Dr. Albanese has undertaken research, with a major focus on assessment and treatment of dual diagnosis patients. He has studied epidemiology, pharmacology, and group therapy. His most recent area of interest has been DUI. DISCLOSURE: Company: Reckitt Benckiser; Forest Type of Relationship: Speaker; Speaker Content Area: Addictions; Addictions

JANICE FAY KAUFFMAN, MPH Reviewer

Janice F. Kauffman R.N., M.P.H., L.A.D.C.1, C.A.S. is The Director of the Addiction Psychiatry Service, Brigham and Women's Hospital, the Vice President of Addiction Treatment Services for North Charles Foundation, Inc., and Assistant Professor of Psychiatry, Harvard Medical School, the Cambridge Hospital. She has work with addictive disorders for the past 34 years in direct treatment, program development and management, teaching, and local and national policy initiatives. She is the founder and President of the Massachusetts Methadone Treatment Providers Association, and the Massachusetts delegate to the American Association for the Treatment of Opioid Dependence Board of Directors. She is on the Board of Directors for the Massachusetts Mental Health and Substance Abuse Association in Massachusetts and past Vice President and now Trustee of the Board of Directors for the American Academy of Health Care Providers in the Addictive Disorders. Areas of expertise include opioid dependence, addicted medical professors, dual diagnosis, pain and addiction, and addictions in general hospitals. DISCLOSURE:

JOHN RENNER, MD Reviewer

Dr. Renner is Associate Professor of Psychiatry, Boston University School of Medicine, Associate Chief of Psychiatry for the VA Boston Healthcare System, and Chief of their Substance Abuse Treatment Program. He graduated from Yale University and Case University School of Medicine and completed his psychiatric residency at the Tufts-New England Medical Center. In addition to his clinical activities at the VA, he is Associate Director of the Boston University Medical Center General Psychiatry Residency Program and Director of their Addiction Psychiatry Residency. Since 1987, Dr. Renner has been a member of the faculty of the Harvard Medical School Division on Addictions. Dr. Renner has written and lectured extensively on the treatment of alcoholism and drug addiction. He is currently a member of the American Psychiatric Association Council on Addiction Psychiatry and is Chairman of the APA Corresponding Committee on Training and Education in Addiction Psychiatry. He is also a member of the Data Safety Monitoring Board for the Clinical Trials Network of the National Institute on Drug Abuse, a member of the Clinical Advisory Committee of the Physician Health Service of the Massachusetts Medical Society, and a Consultant to the Department of Psychiatry, Massachusetts General Hospital. DISCLOSURE:

back to the top

NUMBER OF CREDITS: 3 

Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Upon completion of the course you will get a certificate via e-mail within 2 weeks.

Click the image to view a sample of the certificate

back to the top